Multiple sclerosis (MS) is an autoimmune inflammatory and neurodegenerative disease of
the central nervous system (CNS) with increasing incidence and prevalence. MS is …

Introduction Interferon beta (IFN beta) preparations are an established group of drugs used
for immunomodulation in patients with multiple sclerosis (MS). Subcutaneously (sc) applied …

Importance In patients with multiple sclerosis (MS), factors associated with severe COVID-19
include anti-CD20 therapies and neurologic disability, but it is still unclear whether these 2 …

Background Hearing can be impaired in many neurological conditions and can even
represent a forme fruste of specific disorders. Auditory function can be measured by either …

Menopause, defined as the permanent cessation of ovarian function, represents a period of
significant fluctuation in sex hormone concentrations. Sex hormones including oestrogen …

Background and Objectives It is not possible to fully establish the safety of a disease-
modifying drug (DMD) for multiple sclerosis (MS) from randomized controlled trials as only …

Little is known about disease-modifying drug (DMD) initiation by immigrants with multiple
sclerosis (MS) in countries with universal health coverage. We assessed the association …

Background Much remains unknown surrounding the disease-modifying drugs (DMDs) used
to treat multiple sclerosis and infection-related healthcare use in the 'real-world'setting. We …

The number of ageing people with relapsing multiple sclerosis (RMS) is increasing. The
efficacy of disease-modifying therapies (DMTs) for RMS declines with age. Also, older …

Background and objectives While randomized, controlled trials (RCTs) are the gold standard
for determining treatment efficacy, they do not capture the effectiveness of treatment during …